Management Implications of Evaluating the N2 and N3 Neck After Organ Preservation Therapy
- 1 November 1999
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 109 (11) , 1776-1780
- https://doi.org/10.1097/00005537-199911000-00010
Abstract
Objectives/Hypothesis: To determine if metastatic squamous cell carcinoma with proliferative potential persists in N2 and N3 necks after conventional radiation. Study Design: Retrospective case series. Materials and Methods: We identified 17 patients from our head and neck tumor database who underwent organ-preserving radiotherapy for primary aerodigestive squamous cell cancer and N2-3 regional metastasis. Archival tissue from these 17 neck specimens was evaluated for routine histopathologic evidence of tumor, as well as immunohistochemically for cytokeratin and Ki-67 activity. An assay for apoptosis was also performed on 10 of the specimens. Results: Routine H&E evaluation suggested metastatic cancer in 11 of 17 irradiated neck specimens. Cytokeratin immunostaining confirmed squamous cell carcinoma in these 11 necks as well as 1 additional specimen that had tested H&E negative. Ki-67 staining demonstrated proliferating tumor in 3 of 17 necks. The apoptosis assay confirmed regions of apoptosis in all of the specimens analyzed. Conclusions: The discovery of proliferating cancer cells in 3 of 17 irradiated specimens (18%) supports the practice of planned neck dissection after primary radiotherapy for patients with pretherapeutic N2+ metastatic disease.Keywords
This publication has 17 references indexed in Scilit:
- Preliminary Experience With Thallous Chloride Tl 201--Labeled Single-Photon Emission Computed Tomography Scanning in Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 1996
- HAS THE CELLULAR PROLIFERATION MARKER KI67 ANY CLINICAL RELEVANCE IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK?Clinical Otolaryngology, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991
- Monoclonal antibody Ki‐67: its use in histopathologyHistopathology, 1990
- Neck dissection after twice‐a‐day radiotherapy: Morbidity and recurrence ratesHead & Neck, 1989
- Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 casesRadiotherapy and Oncology, 1986
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981